Patents by Inventor Jeong Jea Seo

Jeong Jea Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-INFECTIVE COMPOUNDS
    Publication number: 20220153756
    Abstract: The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Inventors: JAESEUNG KIM, SUNHEE KANG, JUHEE KANG, SUMI LEE, JEONG JEA SEO, MOOYOUNG SEO
  • Anti-infective compounds
    Patent number: 11279714
    Abstract: The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: March 22, 2022
    Assignee: INSTITUT PASTEUR KOREA
    Inventors: Jaeseung Kim, Sunhee Kang, Juhee Kang, Sumi Lee, Jeong Jea Seo, Mooyoung Seo
  • Anti-Infective Compounds
    Publication number: 20170121349
    Abstract: The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 4, 2017
    Inventors: Jaeseung KIM, Sunhee KANG, Juhee KANG, Sumi LEE, Jeong Jea SEO, Mooyoung SEO
  • Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis
    Patent number: 9371286
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis and a novel sulfonyl amide derivative compound which can be useful for the prevention or treatment of angiogenesis-related diseases or disorders. Since the compound used as an active ingredient in the pharmaceutical composition of the invention is specifically bound to UQCRB and inhibits biological functions thereof, apoptosis is not induced and angiogenic responses are inhibited. Therefore, the compound used as an active ingredient in the pharmaceutical composition of the invention can be useful as an effective and safe angiogenesis inhibitory agent.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: June 21, 2016
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Ho Jeong Kwon, Gyoon Hee Han, Hye Jin Jung, Jeong Jea Seo
  • PHARMACEUTICAL COMPOSITION WITH ENHANCED EFFICACY FOR INHIBITING ANGIOGENESIS
    Publication number: 20140315947
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis and a novel sulfonyl amide derivative compound which can be useful for the prevention or treatment of angiogenesis-related diseases or disorders. Since the compound used as an active ingredient in the pharmaceutical composition of the invention is specifically bound to UQCRB and inhibits biological functions thereof, apoptosis is not induced and angiogenic responses are inhibited. Therefore, the compound used as an active ingredient in the pharmaceutical composition of the invention can be useful as an effective and safe angiogenesis inhibitory agent.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 23, 2014
    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Ho Jeong Kwon, Gyoon Hee Han, Hye Jin Jung, Jeong Jea Seo